Does myeloma secrete an osteoblast inhibiting factor?
Unlike most other tumours, myeloma causes bone destruction without an osteoblastic reaction; we tried to assess whether myeloma secretes a humoral factor that inhibits osteoblasts. Human bone-derived cells were either co-cultured with myeloma cells, or cultured in medium conditioned by myeloma cells. Bone-derived cell growth was measured by cell counts and by uptake of tritiated thymidine (3H-Tdr); growth was inhibited when cultured in medium conditioned by myeloma cells and some inhibition was seen when the bone-derived cells were co-cultured with myeloma cells. The inhibiting effect was dose-dependent and also dependent upon the density of the myeloma cells conditioning the medium. The results of our study suggest that myeloma secretes an osteoblast inhibiting factor of less than 50,000 Dalton molecular weight.
Evans
C E
CE
Hope Hospital, Manchester, England.
Galasko
C S
CS
Ward
C
C
D002452:Cell Count; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D006131:Growth Inhibitors / Q000378:metabolism*; D006801:Humans; D009101:Multiple Myeloma / Q000378:metabolism*; D010006:Osteoblasts / Q000502:physiology*; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D006131:Growth Inhibitors; D014316:Tritium; D013936:Thymidine